Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MDGS

Xylo Technologies (MDGS) Stock Price, News & Analysis

Xylo Technologies logo

About Xylo Technologies Stock (NASDAQ:MDGS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$2.18
$2.95
52-Week Range
N/A
Volume
28,800 shs
Average Volume
9,658 shs
Market Capitalization
$3.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Receive MDGS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xylo Technologies and its competitors with MarketBeat's FREE daily newsletter.

MDGS Stock News Headlines

Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
See More Headlines

MDGS Stock Analysis - Frequently Asked Questions

Shares of Xylo Technologies reverse split before market open on Monday, November 14th 2022. The 1-15 reverse split was announced on Monday, November 14th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, November 14th 2022. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Xylo Technologies investors own include Meta Platforms (META), NVIDIA (NVDA), GE Aerospace (GE), Broadcom (AVGO), CymaBay Therapeutics (cbay), CrowdStrike (CRWD) and

Company Calendar

Today
5/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:MDGS
Employees
77
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$91.86 million
Price / Cash Flow
N/A
Book Value
$51.82 per share
Price / Book
N/A

Miscellaneous

Free Float
1,622,000
Market Cap
$3.92 million
Optionable
Optionable
Beta
0.31
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:MDGS) was last updated on 5/9/2025 by MarketBeat.com Staff
From Our Partners